1. Home
  2. SGRY vs ARDX Comparison

SGRY vs ARDX Comparison

Compare SGRY & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surgery Partners Inc.

SGRY

Surgery Partners Inc.

HOLD

Current Price

$13.69

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.11

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRY
ARDX
Founded
2004
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
SGRY
ARDX
Price
$13.69
$6.11
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$22.25
$15.14
AVG Volume (30 Days)
1.6M
4.1M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
54.14
N/A
EPS
N/A
N/A
Revenue
$1,145,438,000.00
$2,607,000.00
Revenue This Year
$5.09
$37.75
Revenue Next Year
$5.67
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.41
$3.54
52 Week High
$24.10
$8.40

Technical Indicators

Market Signals
Indicator
SGRY
ARDX
Relative Strength Index (RSI) 49.02 44.43
Support Level $13.35 $5.93
Resistance Level $14.94 $6.23
Average True Range (ATR) 0.50 0.26
MACD -0.07 -0.05
Stochastic Oscillator 41.06 9.32

Price Performance

Historical Comparison
SGRY
ARDX

About SGRY Surgery Partners Inc.

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: